Plaque psoriasis Trials in Warsaw, Poland
Conditions / Plaque psoriasis / Warsaw, Poland
Plaque psoriasis has been the subject of sustained clinical investigation across multiple research sites.
42 total trials for this combination
Showing top 10 of 42 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06846541 | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01708629 | Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects | TERMINATED | PHASE3 |
| NCT06095115 | A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02826603 | Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT06108544 | A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period | COMPLETED | PHASE3 |
| NCT06979453 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis | RECRUITING | — |
| NCT06550076 | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06979453 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis | RECRUITING | — |
| NCT07116967 | Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) | RECRUITING | PHASE3 |
| NCT06979453 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis | RECRUITING | — |